Has Richard Morrison, MD received payments from drug or device companies?

Yes. Drug and device makers reported $24,372 in general payments to Richard Morrison, MD across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Morrison, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Morrison, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Morrison, MD

Critical Care Medicine · Shreveport, LANPI 1174644801

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,350 of the $24,372 with a category attached, or 91.7%. AstraZeneca accounts for 67.4% of it on its own, with 3 other manufacturers making up the rest. Among critical care medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,372in general payments, 2019–2025

Across 34 payments — averaging $716.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$16K
Portola Pharmaceuticals, LLC$7K
E.r. Squibb & Sons, L.L.C.$625
Baxter Healthcare$36

What the payments were for

Consulting fees$5002%
Speaking & faculty fees$22,35092%
Travel & lodging$2571%
Food & beverage$1,2655%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	20	$16,420
Portola Pharmaceuticals, LLC	10	$7,291
E.r. Squibb & Sons, L.L.C.	2	$625
Baxter Healthcare	2	$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ANDEXXA$23,599
ELIQUIS$500
CAMZYOS$125

How this compares

$24,372 in reported general payments places this provider in the 95th percentile of 72 critical care medicine providers in Louisiana.

See all critical care medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$64,275

Medicare patients

105

Services billed

569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Shreveport

Laurie GrierShreveport$23K
Jonathan EatonShreveport$19K
Steven ConradShreveport$15K
Cory MarkhamShreveport$3K
Christopher TrosclairShreveport$3K
Sukhmani BoparaiShreveport$2K
Taylor ConradShreveport$2K
Kevin LangloisShreveport$2K
Aiyasawmy DorairajanShreveport$2K
Ajit AlexanderShreveport$2K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →